Kelly, J D <br/><br/>
Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.  [electronic resource] 

 -  British journal of cancer  Jul 2004 
 - 164-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6601895  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Renal Cell--metabolism<br/>Down-Regulation<br/>Humans<br/>Interferon-alpha--pharmacology<br/>Kidney Neoplasms--metabolism<br/>Oligonucleotides, Antisense<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>Thionucleotides--pharmacology<br/>Tumor Cells, Cultured<br/>fas Receptor--pharmacology